Hemophagocytic lymphohistiocytosis in two patients following treatment with pembrolizumab: two case reports and a literature review

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening state of immune hyperactivation. It has the highest mortality rate among all hematological immune-related adverse events (irAEs) of immune checkpoint inhibitors (ICIs) when treating various cancers. However, the pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Yanqiu, He, Wei, Sun, Wei, Wu, Chaojie, Ren, Denghua, Wang, Xinmin, Zhang, Mingshun, Huang, Mao, Ji, Ningfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459512/
https://www.ncbi.nlm.nih.gov/pubmed/36093533
http://dx.doi.org/10.21037/tcr-22-154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459512/
https://www.ncbi.nlm.nih.gov/pubmed/36093533
http://dx.doi.org/10.21037/tcr-22-154

Ejemplares similares